000 01134 a2200301 4500
005 20250515104308.0
264 0 _c20080416
008 200804s 0 0 eng d
022 _a1029-2403
024 7 _a10.1080/10428190701713655
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHenson, Elizabeth S
245 0 0 _aThe role of TRAIL death receptors in the treatment of hematological malignancies.
_h[electronic resource]
260 _bLeukemia & lymphoma
_cJan 2008
300 _a27-35 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aApoptosis
650 0 4 _aGene Expression Regulation
650 0 4 _aHematologic Neoplasms
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aReceptors, TNF-Related Apoptosis-Inducing Ligand
_xgenetics
650 0 4 _aReceptors, Tumor Necrosis Factor
_xgenetics
650 0 4 _aTNF-Related Apoptosis-Inducing Ligand
_xphysiology
700 1 _aJohnston, James B
700 1 _aGibson, Spencer B
773 0 _tLeukemia & lymphoma
_gvol. 49
_gno. 1
_gp. 27-35
856 4 0 _uhttps://doi.org/10.1080/10428190701713655
_zAvailable from publisher's website
999 _c17710946
_d17710946